Serving as chairman of the advisory board, Dr. Zhu has been working closely with BOCG and advises BOCG's investment in Biotech companies since the year 2021, responsible for general scientific advisory for biotech investment Dr. Zhu has over 30 years’ academia and industry experience in the pharmaceutical industry, served as the vice principal of Norman Bethune University of Medical Science from 1995 to 2000. Dr. Zhu also held various positions advising the government policy including National New Drug Advisory Committee, the expert review group of the Life Science Division of the National Natural Science Foundation of China, member of the expert advisory group in Biotechnology of the National Development and Reform Commission, member of the review group of the Innovation Fund for SMEs of the Ministry of Science and Technology of the PRC.

Dr. Zhu obtained his doctoral degree in medicine from Norman Bethune Medical University in April 1989 in the PRC.